Analyst ratings, especially from prominent financial institutions like Morgan Stanley, can significantly influence investor sentiment and stock prices. The Overweight rating and ambitious price target suggest a strong positive outlook for Mural Oncology, likely leading to increased investor interest and a short-term rise in stock price.